Anti-Cancer (Novel Agents): A Review

  • Posted on: 1 August 2014
  • By: admin

Pharma courses

Pharma Admission

pharma courses

pharma admission

Magazine Home


PharmaTutor (August- 2014)
ISSN: 2347 - 7881
(Volume 2, Issue 8)


Received On: 05/06/2014; Accepted On: 09/06/2014; Published On: 01/08/2014


AUTHORS: V. Sravanthi*, Mayure vijay kumar, G.J.Finny, C.P.Meher
Department of pharmaceutical chemistry, Maheshwara College of Pharmacy
Isnapur chitkul ‘X’ road, Patancheru, Hyderabad-502307


Cancer is a class of diseases characterized by out-of-control cell growth. Cancer cells damage the body by multiplying their cells uncontrollably to form masses of tissue named as tumor. Tumors cells can grow and interfere with the digestive, nervous, and circulatory systems, and they can release hormones that alter body function. Tumors that are severe to body are called cancerous tumors, and temporary cells that are affected to body are not harmful and called as benign tumors. Nearly 100’s of cancers are known to be effecting the humans. According to this concern the presented review outlines the novel anticancer agents how they are useful, their mechanism, and chemistry has briefly discussed in this article, the main aim of these review is to evaluate the complete novel anticancer drugs under single review paper.


How to cite this article: V Sravanthi, VK Mayure, GJ Finny, CP Meher; Anti-Cancer (Novel Agents): A Review; PharmaTutor; 2014; 2(8); 119-153